Table 1.
Clinical variables of patients with ER and NER.
| Clinical variables |
Total n = 167 |
NER n = 102 |
ER n = 65 |
P-value* (Chi-square test) |
|---|---|---|---|---|
| Sex | 0.826 | |||
| Female | 27 | 17 | 10 | |
| Male | 140 | 85 | 55 | |
| Age | 0.018 | |||
| <60 | 102 | 55 | 47 | |
| ≥60 | 65 | 47 | 18 | |
| Tumor size (mm) | <0.001 | |||
| <50 | 102 | 74 | 28 | |
| ≥50 | 65 | 28 | 37 | |
| Tumor number | 0.152 | |||
| Single | 155 | 97 | 58 | |
| Multiple | 12 | 5 | 7 | |
| Portal vein invasion | 0.001 | |||
| No | 143 | 95 | 48 | |
| Yes | 24 | 7 | 17 | |
| Liver cirrhosis | 0.794 | |||
| No | 52 | 31 | 21 | |
| Yes | 115 | 71 | 44 | |
| HBV infection | 0.054 | |||
| No | 33 | 25 | 8 | |
| Yes | 134 | 77 | 57 | |
| N/L ratio | 0.039 | |||
| <2.8 | 106 | 71 | 35 | |
| ≥2.8 | 61 | 31 | 30 | |
| ALT (U/L) | 0.417 | |||
| <40 | 104 | 66 | 38 | |
| ≥40 | 63 | 36 | 27 | |
| AST (U/L) | 0.500 | |||
| <50 | 123 | 77 | 46 | |
| ≥50 | 44 | 25 | 19 | |
| AKP (U/L) | 0.054 | |||
| <125 | 131 | 85 | 46 | |
| ≥125 | 36 | 17 | 19 | |
| GGT (U/L) | 0.065 | |||
| <45 | 66 | 46 | 20 | |
| ≥45 | 101 | 56 | 45 | |
| ALB (g/L) | 0.256 | |||
| ≥40 | 165 | 100 | 65 | |
| <40 | 2 | 2 | 0 | |
| TB (μmol/L) | 0.020 | |||
| <20.5 | 122 | 81 | 41 | |
| ≥20.5 | 45 | 21 | 24 | |
| AFP (μg/L) | 0.003 | |||
| <9 | 50 | 39 | 11 | |
| ≥9 | 117 | 63 | 54 | |
| CP level | 0.132 | |||
| A | 140 | 89 | 51 | |
| B | 27 | 13 | 14 | |
| BCLC stage | <0.001 | |||
| 0 | 22 | 17 | 5 | |
| A | 117 | 78 | 39 | |
| B | 4 | 1 | 3 | |
| C | 24 | 6 | 18 |
*P <0.05 means significant difference. The bold values indicate P values <0.05 are highlighted. The bold values indicate the best results.